Business Description
ImageneBio Inc. is a San Diego-based medical company focused on developing treatments for people living with autoimmune and inflammatory conditions. Its primary drug in development, IMG-007, works by targeting a specific protein on immune cells to help reduce harmful inflammation, and is currently being tested in clinical trials. The company was previously known as Ikena Oncology Inc. before adopting its current name in July 2025.
